Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly is a rare, central nervous system malformation syndrome characterized by progressive microcephaly with profound motor delay and intellectual disability, associated with hypertonia, spasticity, clonus, and seizures, with brain imaging revealing severe cerebral and cerebellar atrophy, and poor myelination.
Features include always present findings: Hypertonia, Clonus, Difficulty swallowing (dysphagia), and Hypsarrhythmia and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Clonus, Difficulty swallowing (dysphagia), Hypoplasia of the brainstem |
MED17 encodes mediator complex subunit 17 (651 aa). Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Highest expression in Ovary (16.3 TPM) and Cervix Endocervix (14.8 TPM).
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly is associated with mutations in the MED17 gene on chromosome 11.
MED17 is classified as a druggable target (Transcription Factor and Transcription Factor Complex categories) with score 0.0.
Genetic testing for MED17 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 15 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly.
3 publications have been identified in PubMed for infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Gene Therapy / Novel Therapeutics (33%).
Micale L (2026). [PMID: 42202558](https://pubmed.ncbi.nlm.nih.gov/42202558/). *Mol Genet Metab*. [Gene Therapy / Novel Therapeutics]
Aughey GN (2025). [PMID: 39692517](https://pubmed.ncbi.nlm.nih.gov/39692517/). *Brain : a journal of neurology*. [Case Report / Case Series]
Aughey G (2024). [PMID: 38746364](https://pubmed.ncbi.nlm.nih.gov/38746364/). *medRxiv : the preprint server for health sciences*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 9:11 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
2 |
Difficulty swallowing (dysphagia), Feeding difficulties |
Head and neck | 1 | Secondary microcephaly |
Growth and development | 1 | Failure to thrive |
Muscles | 1 | Diffuse cerebral atrophy |